Rapid SDH vs Viz Subdural+

Direct competitors — feature-level head-to-head below. Comparability 90/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by RapidAI (formerly iSchemaView)
VS
by Viz.ai

AI Verdict

Both Rapid SDH and Viz Subdural+ are FDA-cleared AI tools designed for the detection of acute and chronic subdural hematomas on non-contrast CT scans, aiming to expedite neurocritical care. Rapid SDH emphasizes rapid notifications and high diagnostic accuracy, while Viz Subdural+ distinguishes itself with automatic labeling and quantification of subdural collections, including volume, thickness, and midline shift, integrated into a care coordination platform. The choice between them may depend on the specific need for speed and integration into a broader trauma suite versus detailed quantification and comprehensive care coordination.

Choose Rapid SDH if…

Choose Rapid SDH if your primary need is ultra-rapid detection and notification of suspected subdural hematomas to accelerate time-sensitive neurocritical care decisions. This tool is ideal for emergency departments and trauma centers where every minute counts in identifying potential life-threatening conditions and initiating immediate patient management.

View Rapid SDH →

Choose Viz Subdural+ if…

Choose Viz Subdural+ if your workflow requires not only rapid detection but also automated labeling and precise quantification of subdural hemorrhages, including volume, thickness, and midline shift. This solution is particularly beneficial for comprehensive diagnosis, surgical planning, and streamlining care coordination across a multidisciplinary team for neurovascular conditions.

View Viz Subdural+ →

When choosing between Rapid SDH by RapidAI and Viz Subdural+ by Viz.ai, physicians should consider their primary need: speed of notification versus comprehensive quantification and care coordination. Rapid SDH excels in its rapid notification system, designed to alert clinicians to suspected acute and chronic subdural hematomas in under a minute. This tool is ideal for emergency and neurocritical care settings where immediate alerts are paramount for accelerating time-sensitive decisions. Its high positive predictive value for SDHs greater than 1ml further supports its utility in rapid triage and initial assessment.

Viz Subdural+, on the other hand, offers a more comprehensive approach by not only detecting but also automatically labeling and quantifying subdural hemorrhages, including measurements like volume, thickness, and midline shift. This makes Viz Subdural+ particularly beneficial for neurosurgeons and neurologists who require detailed anatomical information for treatment planning and ongoing patient management. The key practical difference lies in Rapid SDH’s focus on immediate, high-sensitivity alerts for initial decision-making, while Viz Subdural+ provides richer, quantitative data integrated into a broader care coordination platform. Physicians prioritizing rapid alerts for time-critical interventions may lean towards Rapid SDH, whereas those needing detailed measurements and streamlined care coordination for neurovascular conditions would find Viz Subdural+ more suitable.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Rapid SDH Viz Subdural+
Pricing Contact vendor Subscription model
Deployment Cloud-based, On-premise Cloud-native platform, available as part of the Viz.ai One platform.
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz Subdural+

Both tools offer rapid notifications and aim to streamline workflows. However, Viz Subdural+ integrates into the broader Viz.ai One platform, which includes HIPAA-compliant care team communication features, potentially offering a more comprehensive and collaborative user experience. Rapid SDH also provides mobile, PACS, and email notifications, and emphasizes quick implementation.

Clinical Value

Viz Subdural+

While Rapid SDH provides strong detection capabilities with high sensitivity and specificity for SDHs, Viz Subdural+ goes a step further by offering automated detection, labeling, and quantification of measurements including volume, thickness, and midline shift. This quantification provides more granular, actionable data for clinical decision-making and monitoring, making it a more comprehensive solution.

Pricing & Value

Tie

Both tools operate on enterprise pricing models that require direct contact with the vendor for a quote, lacking full public transparency. While RapidAI mentions a potential starting price for a single module and emphasizes cost-effectiveness, Viz.ai also highlights reduced hospital costs and improved patient outcomes as part of its value proposition. Without specific comparative pricing, it's difficult to definitively declare a winner on value.

Enterprise Readiness

Rapid SDH

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, demonstrating strong enterprise readiness. Rapid SDH offers deployment flexibility with both cloud-based and on-premise options, which can be crucial for diverse hospital IT environments. Viz Subdural+ is cloud-native and part of a widely adopted platform, but the on-premise option gives Tool A a slight edge in adaptability.

Innovation

Viz Subdural+

Both are innovative AI solutions for SDH detection. However, Viz Subdural+ stands out with its automated labeling and quantification of subdural hemorrhage measurements like volume, thickness, and midline shift, which it claims is a 'first and only' comprehensive solution. This provides a more advanced level of analysis and actionable insights beyond basic detection.

Support & Docs

Viz Subdural+

Both companies offer robust customer support. RapidAI provides 24/7/365 global support and various learning resources. Viz.ai, however, details a dedicated customer success team with specialized roles like Clinical and Workflow Specialists and Customer Success Managers, along with a guaranteed 15-minute response time for urgent issues, indicating a more structured and proactive support ecosystem.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Rapid SDH Viz Subdural+
Product Name Rapid SDH Viz Subdural+
Company RapidAI (formerly iSchemaView) Viz.ai
Detection Capabilities AI-powered detection of suspected hemispheric acute and chronic subdural hematoma (SDH) Auto-detection of suspected acute and chronic subdural hemorrhages; Automatic labeling of subdural collections
Notification Time Notifications to clinicians in one minute or less Not specified
Quantification of Measurements Not specified Quantification of measurements including volume, thickness, and midline shift
Integration Integration with Rapid mobile app, PACS, and email for notifications; Part of a comprehensive hemorrhagic and trauma care AI solution (with Rapid ICH and Rapid Hyperdensity) Integration into the Viz.ai One platform; HIPAA-compliant platform for care team communication

Videos

Demos, reviews, and walkthroughs featuring Rapid SDH and Viz Subdural+.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Rapid SDH by RapidAI focuses on rapid detection of suspected acute and chronic subdural hematomas. Viz Subdural+ by Viz.ai, on the other hand, provides automatic labeling of subdural collections and quantification of measurements including volume, thickness, and midline shift.
Rapid SDH is designed to deliver notifications to clinicians in under one minute to accelerate neurocritical care decisions. Viz Subdural+ aims to streamline diagnosis and care coordination but does not specify a precise notification timeframe in the provided information.
Rapid SDH offers integration with the Rapid mobile app, PACS, and email for notifications, and is part of a comprehensive hemorrhagic and trauma care AI solution. Viz Subdural+ is available as part of the Viz.ai One platform, which also facilitates HIPAA-compliant care team communication.
Rapid SDH reports a high positive predictive value (PPV) of 99%, with 93% sensitivity and 99% specificity for SDHs >1ml. The provided information for Viz Subdural+ does not include specific performance metrics like sensitivity, specificity, or PPV in its description, though other sources indicate strong performance in identifying and quantifying SDHs.

Backers

Who funded each tool's parent company.

Viz Subdural+

AI Tool Finder
AI-powered search. Results may not be comprehensive.